• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ITC 介导的 SIX1 泛素化对鼻咽癌中 CDC27-cyclinB1 信号的影响。

Implications of ITCH-mediated ubiquitination of SIX1 on CDC27-cyclinB1 signaling in nasopharyngeal carcinoma.

机构信息

Department of Otolaryngology, Head and Neck Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, Hubei, China.

Sleep Medicine Centre, Zhongnan Hospital of Wuhan University, Wuhan, 430071, Hubei, China.

出版信息

Sci Rep. 2024 Oct 15;14(1):24140. doi: 10.1038/s41598-024-73239-5.

DOI:10.1038/s41598-024-73239-5
PMID:39406717
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11480102/
Abstract

Nasopharyngeal carcinoma (NPC) presents a significant medical challenge due to its high incidence rate and poor prognosis, which are attributed primarily to tumor metastasis and drug resistance. Sine oculis homeobox homolog 1 (SIX1) has been identified as a crucial target for cancer treatment. However, its role in NPC remains incompletely understood. This study investigated the mechanisms by which the degradation of the SIX1 protein, which is mediated by ubiquitin, affects the malignant characteristics of NPC throughout the cell cycle. Our findings reveal that reduced expression of the itchy E3 ubiquitin ligase E3 (ITCH) in NPC impedes the degradation of the SIX1 protein, leading to enhance oncogenic properties. Knockdown experiments which SIX1 was inhibited demonstrated a decrease in the proliferation, migration, and invasion of NPC cell lines, whereas overexpression of SIX1 yielded the opposite effects. Further experimental validation revealed that SIX1 promotes NPC progression via the cell division cycle 27 (CDC27)/cyclin B1 axis. These findings provide valuable insights into potential therapeutic targets and prognostic indicators for NPC treatment, emphasizing the ITCH/SIX1/CDC27/cyclin B1 axis as a promising target for novel therapies.

摘要

鼻咽癌(NPC)由于其高发病率和预后不良,是一个重大的医学挑战,主要归因于肿瘤转移和耐药性。Sine oculis homeobox homolog 1(SIX1)已被确定为癌症治疗的重要靶点。然而,其在 NPC 中的作用仍不完全清楚。本研究探讨了泛素介导的 SIX1 蛋白降解如何通过细胞周期影响 NPC 的恶性特征。我们的研究结果表明,NPC 中瘙痒 E3 泛素连接酶 E3(ITCH)表达降低会阻碍 SIX1 蛋白的降解,从而增强致癌特性。抑制 SIX1 的敲低实验表明,NPC 细胞系的增殖、迁移和侵袭减少,而 SIX1 的过表达则产生相反的效果。进一步的实验验证表明,SIX1 通过细胞分裂周期 27(CDC27)/细胞周期蛋白 B1 轴促进 NPC 的进展。这些发现为 NPC 治疗提供了有价值的治疗靶点和预后指标,强调了 ITCH/SIX1/CDC27/细胞周期蛋白 B1 轴作为新型治疗方法的有前途的靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a9/11480102/110fc2cedaf8/41598_2024_73239_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a9/11480102/485f9d0a8536/41598_2024_73239_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a9/11480102/ad4709c35519/41598_2024_73239_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a9/11480102/bb2f57c78d34/41598_2024_73239_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a9/11480102/1090f2b90731/41598_2024_73239_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a9/11480102/81ea1f49c36b/41598_2024_73239_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a9/11480102/f1e2f953426f/41598_2024_73239_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a9/11480102/afd8e4bfa0ad/41598_2024_73239_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a9/11480102/87ff8ef684e3/41598_2024_73239_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a9/11480102/2cf387e4e9b4/41598_2024_73239_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a9/11480102/49c83e43c506/41598_2024_73239_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a9/11480102/110fc2cedaf8/41598_2024_73239_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a9/11480102/485f9d0a8536/41598_2024_73239_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a9/11480102/ad4709c35519/41598_2024_73239_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a9/11480102/bb2f57c78d34/41598_2024_73239_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a9/11480102/1090f2b90731/41598_2024_73239_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a9/11480102/81ea1f49c36b/41598_2024_73239_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a9/11480102/f1e2f953426f/41598_2024_73239_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a9/11480102/afd8e4bfa0ad/41598_2024_73239_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a9/11480102/87ff8ef684e3/41598_2024_73239_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a9/11480102/2cf387e4e9b4/41598_2024_73239_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a9/11480102/49c83e43c506/41598_2024_73239_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a9/11480102/110fc2cedaf8/41598_2024_73239_Fig11_HTML.jpg

相似文献

1
Implications of ITCH-mediated ubiquitination of SIX1 on CDC27-cyclinB1 signaling in nasopharyngeal carcinoma.ITC 介导的 SIX1 泛素化对鼻咽癌中 CDC27-cyclinB1 信号的影响。
Sci Rep. 2024 Oct 15;14(1):24140. doi: 10.1038/s41598-024-73239-5.
2
Circular RNA ITCH attenuates the progression of nasopharyngeal carcinoma by inducing PTEN upregulation via miR-214.环状RNA ITCH通过miR-214诱导PTEN上调来减弱鼻咽癌的进展。
J Gene Med. 2022 Jan;24(1):e3391. doi: 10.1002/jgm.3391. Epub 2021 Nov 11.
3
MiR-2110 induced by chemically synthesized cinobufagin functions as a tumor-metastatic suppressor via targeting FGFR1 to reduce PTEN ubiquitination degradation in nasopharyngeal carcinoma.化学合成的华蟾毒精诱导的 miR-2110 通过靶向 FGFR1 减少鼻咽癌中 PTEN 的泛素化降解,从而发挥肿瘤转移抑制作用。
Environ Toxicol. 2024 Jun;39(6):3548-3562. doi: 10.1002/tox.24197. Epub 2024 Mar 13.
4
Increased expression is a potential unfavourable factor promoting the growth of nasopharyngeal carcinoma.表达增加是促进鼻咽癌生长的一个潜在不利因素。
J Int Med Res. 2024 Sep;52(9):3000605241271754. doi: 10.1177/03000605241271754.
5
LASP1 promotes nasopharyngeal carcinoma progression through negatively regulation of the tumor suppressor PTEN.LASP1 通过负向调控肿瘤抑制因子 PTEN 促进鼻咽癌的进展。
Cell Death Dis. 2018 Mar 12;9(3):393. doi: 10.1038/s41419-018-0443-y.
6
PLUNC inhibits invasion and metastasis in nasopharyngeal carcinoma by inhibiting NLRP3 inflammasome activation.PLUNC 通过抑制 NLRP3 炎性小体的激活抑制鼻咽癌的侵袭和转移。
Biochim Biophys Acta Mol Basis Dis. 2024 Oct;1870(7):167352. doi: 10.1016/j.bbadis.2024.167352. Epub 2024 Jul 14.
7
Circular RNA circRNF13 inhibits proliferation and metastasis of nasopharyngeal carcinoma via SUMO2.环状 RNA circRNF13 通过 SUMO2 抑制鼻咽癌的增殖和转移。
Mol Cancer. 2021 Aug 31;20(1):112. doi: 10.1186/s12943-021-01409-4.
8
NAP1L1 targeting suppresses the proliferation of nasopharyngeal carcinoma.靶向 NAP1L1 可抑制鼻咽癌的增殖。
Biomed Pharmacother. 2021 Nov;143:112096. doi: 10.1016/j.biopha.2021.112096. Epub 2021 Sep 23.
9
LPLUNC1 stabilises PHB1 by counteracting TRIM21-mediated ubiquitination to inhibit NF-κB activity in nasopharyngeal carcinoma.LPLUNC1 通过拮抗 TRIM21 介导的泛素化稳定 PHB1,从而抑制鼻咽癌中的 NF-κB 活性。
Oncogene. 2019 Jun;38(25):5062-5075. doi: 10.1038/s41388-019-0778-6. Epub 2019 Mar 18.
10
Homeodomain protein DLX4 facilitates nasopharyngeal carcinoma progression via up-regulation of YB-1.同源结构域蛋白 DLX4 通过上调 YB-1 促进鼻咽癌的进展。
Genes Cells. 2020 Jul;25(7):466-474. doi: 10.1111/gtc.12772. Epub 2020 May 11.

引用本文的文献

1
Necroptosis in cancer: insight from epigenetic, post-transcriptional and post-translational modifications.癌症中的坏死性凋亡:来自表观遗传、转录后和翻译后修饰的见解
J Hematol Oncol. 2025 Jul 30;18(1):77. doi: 10.1186/s13045-025-01726-x.
2
Identification and validation of CDC20 and ITCH as ubiquitination related biomarker in idiopathic pulmonary fibrosis.鉴定并验证CDC20和ITCH作为特发性肺纤维化中泛素化相关生物标志物
Hereditas. 2025 Apr 1;162(1):50. doi: 10.1186/s41065-025-00401-y.

本文引用的文献

1
BCLAF1 drives esophageal squamous cell carcinoma progression through regulation of YTHDF2-dependent SIX1 mRNA degradation.BCLAF1 通过调控 YTHDF2 依赖的 SIX1 mRNA 降解促进食管鳞癌进展。
Cancer Lett. 2024 Jun 1;591:216874. doi: 10.1016/j.canlet.2024.216874. Epub 2024 Apr 16.
2
A converged ubiquitin-proteasome pathway for the degradation of TOC and TOM tail-anchored receptors.TOC 和 TOM 尾部锚定受体降解的融合泛素蛋白酶体途径。
J Integr Plant Biol. 2024 May;66(5):1007-1023. doi: 10.1111/jipb.13645. Epub 2024 Mar 19.
3
CARM1 drives triple-negative breast cancer progression by coordinating with HIF1A.
CARM1 通过与 HIF1A 协调驱动三阴性乳腺癌进展。
Protein Cell. 2024 Oct 1;15(10):744-765. doi: 10.1093/procel/pwae010.
4
Novel LncRNA LINC02936 Suppresses Ferroptosis and Promotes Tumor Progression by Interacting with SIX1/CP Axis in Endometrial Cancer.新型长链非编码 RNA LINC02936 通过与 SIX1/CP 轴相互作用抑制铁死亡并促进子宫内膜癌进展。
Int J Biol Sci. 2024 Jan 27;20(4):1356-1374. doi: 10.7150/ijbs.86256. eCollection 2024.
5
Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers.抑制 YAP-MMB 相互作用和靶向 NEK2 作为 YAP 驱动型癌症的潜在治疗策略。
Oncogene. 2024 Feb;43(8):578-593. doi: 10.1038/s41388-023-02926-w. Epub 2024 Jan 5.
6
GSK3β phosphorylates Six1 transcription factor and regulates its APC/C mediated proteosomal degradation.GSK3β 磷酸化 Six1 转录因子并调节其 APC/C 介导的蛋白酶体降解。
Cell Signal. 2024 Mar;115:111030. doi: 10.1016/j.cellsig.2023.111030. Epub 2023 Dec 30.
7
IL-33 potentiates histaminergic itch.白细胞介素-33增强组胺能性瘙痒。
J Allergy Clin Immunol. 2024 Mar;153(3):852-859.e3. doi: 10.1016/j.jaci.2023.08.038. Epub 2023 Nov 18.
8
Altered binding affinity of SIX1-Q177R correlates with enhanced WNT5A and WNT pathway effector expression in Wilms tumor.SIX1-Q177R 的结合亲和力改变与肾母细胞瘤中 WNT5A 和 WNT 通路效应物表达增强相关。
Dis Model Mech. 2023 Nov 1;16(11). doi: 10.1242/dmm.050208. Epub 2023 Nov 17.
9
FDA Approval Summary: Tremelimumab in Combination with Durvalumab for the Treatment of Patients with Unresectable Hepatocellular Carcinoma.FDA 批准概要:Tremelimumab 联合 Durvalumab 治疗不可切除肝细胞癌患者。
Clin Cancer Res. 2024 Jan 17;30(2):269-273. doi: 10.1158/1078-0432.CCR-23-2124.
10
Nucleosome assembly protein 1 like 1 (NAP1L1) promotes cardiac fibrosis by inhibiting YAP1 ubiquitination and degradation.核小体组装蛋白1样蛋白1(NAP1L1)通过抑制Yes相关蛋白1(YAP1)的泛素化和降解来促进心脏纤维化。
MedComm (2020). 2023 Aug 15;4(5):e348. doi: 10.1002/mco2.348. eCollection 2023 Oct.